Core Insights - The company is seizing unprecedented opportunities in the health industry driven by global demographic changes and rising health awareness, particularly in China, where the aging population and digital technology are expanding the "silver economy" market [1][3] - The company aims to build a comprehensive health service ecosystem covering prevention, diagnosis, medication, rehabilitation, and care, contributing significantly to its revenue [1] Group 1: Smart Health Management Platform - The company has established a wholly-owned subsidiary, Shenzhen Can Dong Health Technology Co., Ltd., and formed a research team focused on health data analysis and intelligent services [1] - The platform will integrate dynamic vital sign monitoring, intelligent risk assessment, personalized health interventions, and medication reminders, with plans to connect to medical institutions and home care scenarios [2] - The company plans to increase investment in general artificial intelligence and big data systems in the health sector over the next three years, expecting significant revenue growth once the platform is operational [2] Group 2: High-End Medical and Health Services - The company is expanding its business in the medical and health care sector to meet the growing demand for high-quality care, having signed strategic cooperation agreements with several enterprises [3] - A joint venture has been established in Anhui to explore the development of biomedicine, rehabilitation care, and health management in the Greater China region [3] - The joint venture is expected to generate positive cash flow for the company by 2026 [3] Group 3: Health and Personal Care Product Trade - The company is enhancing its channel and supply chain layout in the health and personal care product market, which is projected to grow significantly [4] - The company plans to strengthen its e-commerce presence and establish a comprehensive supply chain system covering both online and offline channels [4] - Initial cooperation agreements have been reached with suppliers from various regions, with expectations of stable revenue generation by Q4 2025 and market share growth in 2026 and 2027 [4] Group 4: Strategic Initiatives - The company's strategy focuses on integrating technology with health services and product offerings to create a complete business chain [4] - Continued investment in digitalization, general artificial intelligence, and biotechnology is planned to enhance service capabilities and industry competitiveness [4] - The company believes these initiatives will enrich its business structure and create long-term sustainable value for shareholders and investors [4]
智慧健康科技：重点发力大健康、数字医疗与康养服务